5 results for "drug development"
🧘 Health & WellnessAI Catches Cancer Earlier, Cuts Drug Development to 30 Days
Artificial intelligence is revolutionizing healthcare by spotting diseases doctors might miss and slashing decade-long drug development timelines to just one month. From detecting cancer on scans with 97% accuracy to predicting which treatments will work best for individual patients, AI is giving doctors superpowers while keeping them in control.
🚀 InnovationNSF Invests $400M in AI and Quantum Research Breakthroughs
The National Science Foundation poured more than $400 million into cutting-edge technology in 2025, connecting 400 research teams to shared AI tools and helping scientists build the largest quantum computer array ever recorded. These investments are bringing faster drug development, ultra-secure communications, and revolutionary computing power closer to reality.
🚀 InnovationScientists Resurrect Ancient Cannabis Enzymes for New Medicines
Researchers in the Netherlands brought million-year-old cannabis enzymes back to life, unlocking a breakthrough that could create new medications for inflammation, seizures, and bacterial infections. The ancient enzymes are more flexible and easier to produce than modern versions, opening doors to medicines we couldn't make before.
🚀 InnovationDutch Scientists Resurrect Ancient Cannabis Enzymes to Create Breakthrough Medicines
Researchers at Wageningen University in the Netherlands have brought ancient cannabis enzymes back to life, unlocking a treasure trove of possibilities for developing new medicines. These remarkable "generalist" enzymes from millions of years ago could revolutionize how we produce therapeutic compounds and treat inflammation, seizures, and bacterial infections.
🎬 VideosAurora Brings Hope to Millions Living with Rare Diseases Through AI Innovation
Healthcare innovator Aurora is harnessing the power of artificial intelligence to develop life-changing therapies for the millions of patients worldwide who suffer from rare diseases. Backed by leading venture capital firm Menlo Ventures, this groundbreaking approach promises to bring treatment options to those who have long been overlooked by traditional pharmaceutical development.